CRISPR Therapeutics

About

CRISPR Therapeutics is Switzerland's leading biotechnology company based in Basel. The company focuses on CRISPR gene editing technology, rare hematological diseases, tumors and other biotechnology fields, and uses cutting-edge technologies such as genetic engineering, cell therapy, and protein engineering to develop innovative rare disease treatment products. The company has a strong R & D team and advanced technology platform, and is committed to transforming the latest biotechnology achievements into clinically available treatment options.

Specialties

• CRISPR gene editing technology
• Rare blood disease
• tumor

Achievements

• Develop CRISPR gene editing technology innovative biotechnology products
• Obtained multiple international biotechnology patents
• Completed multiple rounds of financing with a valuation of more than US$500 million
• Establish strategic partnerships with the world's top pharmaceutical companies